Focused on the advancement of new applications for CRISPR-based technologies
Exploring the vast potential of CRISPR-Cas technology across therapeutics, agricultural biotech, biological research and industrial biotech
Engineering any genome, at any site, in any way
◄
►
Patent granted for groundbreaking work by Jennifer Doudna’s and Emmanuelle Charpentier’s research teams in CRISPR/Cas9 genome editing technology  Patent covers use of optimized guide RNA molecules ZUG, Switzerland and CAMBRIDGE, Mass. and...
Caribou Biosciences is a pioneer in the revolutionary field of CRISPR-Cas genome editing.  Our proprietary technology puts us at the forefront of the development of new medical therapies and bio-based products which offer profound benefits to both human health and society as a whole. 
Our singular focus is on the advancement of new applications for CRISPR-Cas gene editing that will help bring the tremendous promise this technology holds for patients and consumers to reality.
© 2018 Caribou Biosciences, Inc. All rights reserved.
­